US$ 24.12
fda warning bpc-157 unapproved drug peptide RECENT NEW CONTENT bpc-157 fda warning unapproved peptide
Description
The capsule formulation offers researchers advantages over powder form including reduced exposure risk, better handling characteristics and more consistent experimental parameters

The medication's half-life of approximately five days allows for steady-state concentrations to be reached after about 4 weeks

Hydrochloric acid and/or sodium hydroxide may have been added during manufacture to adjust the pH (range 4.5 to 7.0)

Baseline Labs supplies high quality bacteriostatic water in both 3ml and 10ml sterile vials, allowing researchers to select the most convenient size depending on the volume required for reconstitution